Abstract
The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase II trials in Barrett's adenocarcinoma; statins in chemoprevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.
Original language | English |
---|---|
Pages (from-to) | 108-126 |
Number of pages | 19 |
Journal | Annals of the New York Academy of Sciences |
Volume | 1325 |
Early online date | 29 Sep 2014 |
DOIs | |
Publication status | Published - Sep 2014 |
Event | 12th OESO World Conference: Cancers of the Esophagus - Paris, France Duration: 27 Aug 2013 → 30 Aug 2013 |
Keywords
- animal reflux–inflammation models
- Barrett's adenocarcinoma
- elofrnithine
- COXIBs
- PPIs
- statins
- biomarkers
- OESO